Nevertheless, the fact remains that tumors associated with ER positivity, specifically those in the luminal breast cancer subgroups, tend to express more cyclin D1 on the mRNA and protein levels than do those that are ER negative. The gene discussed is CCND1; the disease is breast carcinoma.